[go: up one dir, main page]

GB9810181D0 - Novel formulations - Google Patents

Novel formulations

Info

Publication number
GB9810181D0
GB9810181D0 GBGB9810181.9A GB9810181A GB9810181D0 GB 9810181 D0 GB9810181 D0 GB 9810181D0 GB 9810181 A GB9810181 A GB 9810181A GB 9810181 D0 GB9810181 D0 GB 9810181D0
Authority
GB
United Kingdom
Prior art keywords
novel formulations
formulations
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9810181.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9810181.9A priority Critical patent/GB9810181D0/en
Publication of GB9810181D0 publication Critical patent/GB9810181D0/en
Priority to IL13959499A priority patent/IL139594A0/en
Priority to IDW20002347A priority patent/ID28019A/en
Priority to CA002331871A priority patent/CA2331871A1/en
Priority to BR9910401-6A priority patent/BR9910401A/en
Priority to PCT/GB1999/001520 priority patent/WO1999058113A2/en
Priority to SK1714-2000A priority patent/SK17142000A3/en
Priority to TR2000/03350T priority patent/TR200003350T2/en
Priority to APAP/P/2000/002019A priority patent/AP2000002019A0/en
Priority to PL99344573A priority patent/PL344573A1/en
Priority to HU0102064A priority patent/HUP0102064A2/en
Priority to CN99808325A priority patent/CN1308521A/en
Priority to AU39409/99A priority patent/AU3940999A/en
Priority to KR1020007012706A priority patent/KR20010043574A/en
Priority to JP2000547965A priority patent/JP2002514591A/en
Priority to EP99922302A priority patent/EP1077682A2/en
Priority to EA200001174A priority patent/EA200001174A1/en
Priority to NO20005683A priority patent/NO20005683L/en
Priority to ZA200006562A priority patent/ZA200006562B/en
Priority to BG105010A priority patent/BG105010A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB9810181.9A 1998-05-13 1998-05-13 Novel formulations Ceased GB9810181D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
EA200001174A EA200001174A1 (en) 1998-05-13 1999-05-13 NEW READY PREPARATORY FORM CONTAINING PAROXETIN
APAP/P/2000/002019A AP2000002019A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine.
HU0102064A HUP0102064A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine and process for its preparation
CA002331871A CA2331871A1 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
BR9910401-6A BR9910401A (en) 1998-05-13 1999-05-13 New formulation containing paroxetine
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
SK1714-2000A SK17142000A3 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
TR2000/03350T TR200003350T2 (en) 1998-05-13 1999-05-13 New formulation containing paroxetine.
IL13959499A IL139594A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
PL99344573A PL344573A1 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
IDW20002347A ID28019A (en) 1998-05-13 1999-05-13 A NEW FORMULATION THAT CONTAINS PAROXOXINE
CN99808325A CN1308521A (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
AU39409/99A AU3940999A (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
KR1020007012706A KR20010043574A (en) 1998-05-13 1999-05-13 Novel Formulation Containing Paroxetine
JP2000547965A JP2002514591A (en) 1998-05-13 1999-05-13 Formulations containing new paroxetine
EP99922302A EP1077682A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
NO20005683A NO20005683L (en) 1998-05-13 2000-11-10 New formulation containing paroxetine
ZA200006562A ZA200006562B (en) 1998-05-13 2000-11-13 Novel formulation containing paroxetine.
BG105010A BG105010A (en) 1998-05-13 2000-11-30 Medicamentous form containing paroxetine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations

Publications (1)

Publication Number Publication Date
GB9810181D0 true GB9810181D0 (en) 1998-07-08

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9810181.9A Ceased GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations

Country Status (20)

Country Link
EP (1) EP1077682A2 (en)
JP (1) JP2002514591A (en)
KR (1) KR20010043574A (en)
CN (1) CN1308521A (en)
AP (1) AP2000002019A0 (en)
AU (1) AU3940999A (en)
BG (1) BG105010A (en)
BR (1) BR9910401A (en)
CA (1) CA2331871A1 (en)
EA (1) EA200001174A1 (en)
GB (1) GB9810181D0 (en)
HU (1) HUP0102064A2 (en)
ID (1) ID28019A (en)
IL (1) IL139594A0 (en)
NO (1) NO20005683L (en)
PL (1) PL344573A1 (en)
SK (1) SK17142000A3 (en)
TR (1) TR200003350T2 (en)
WO (1) WO1999058113A2 (en)
ZA (1) ZA200006562B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
AU2002330771A1 (en) * 2001-10-22 2003-06-10 Synthon B.V. N-formyl derivatives of paroxetine
GB2636182A (en) * 2023-12-04 2025-06-11 Novumgen Ltd An orally disintegrating tablet of paroxetine and its process of preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
IL130856A (en) * 1997-01-15 2001-09-13 Smithkline Beecham Plc Spray-dried paroxetine compositions and their preparation
NZ505123A (en) * 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof

Also Published As

Publication number Publication date
KR20010043574A (en) 2001-05-25
CN1308521A (en) 2001-08-15
ZA200006562B (en) 2002-02-13
PL344573A1 (en) 2001-11-05
AU3940999A (en) 1999-11-29
ID28019A (en) 2001-05-03
HUP0102064A2 (en) 2002-05-29
TR200003350T2 (en) 2001-03-21
NO20005683D0 (en) 2000-11-10
AP2000002019A0 (en) 2000-12-31
EA200001174A1 (en) 2001-06-25
WO1999058113A2 (en) 1999-11-18
WO1999058113A3 (en) 2000-02-17
BG105010A (en) 2001-07-31
SK17142000A3 (en) 2001-06-11
NO20005683L (en) 2000-12-05
CA2331871A1 (en) 1999-11-18
EP1077682A2 (en) 2001-02-28
BR9910401A (en) 2001-01-09
JP2002514591A (en) 2002-05-21
IL139594A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
GB9804013D0 (en) Formulations
GB9715751D0 (en) Formulations
AP2000001874A0 (en) Cellecoxib compositions
IL139541A0 (en) Novel particulate formulations
PL341642A1 (en) Novel macrolydes
GB9811377D0 (en) Compositions
EP1068213A4 (en) Novel aminoorganofunctionalsiloxanes
IL139733A0 (en) Novel compositions
GB9806312D0 (en) Novel formulations
GB9805782D0 (en) Compositions
GB2339693B (en) Anti-mollusc compositions
GB9827291D0 (en) Compositions
GB9815002D0 (en) Formulations
GB9810180D0 (en) Novel formulation
GB0016470D0 (en) Compositions
GB9806810D0 (en) Compositions
GB9815001D0 (en) Formulations
GB2336535B (en) Compositions
GB9810181D0 (en) Novel formulations
GB9809347D0 (en) Compositions
GB9605948D0 (en) Novel formulations
GB9818910D0 (en) Novel formulation
GB9818905D0 (en) Novel formulation
GB9704521D0 (en) Formulations
GB9703099D0 (en) Formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)